Product Information
OXYMORPHONE HCL 10 MG TABLET is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $1.2245 per EA under NDC 00054028425. Its NADAC has been published 638 times since Nov 28, 2013.
Strength
10 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054028425
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
5/21/2025
Active Ingredients
OXYMORPHONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090964On Market Since
9/27/2010
Pharmacological Classes
Price Statistics
The NADAC for OXYMORPHONE HCL 10 MG TABLET has been published 638 times since Nov 28, 2013, and over the history we have for it it has declined 66.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2245 per EA |
|---|---|
| All-time high | $3.7252 (Jan 15, 2014) |
| All-time low | $0.2729 (Jul 21, 2021) |
| 52-week high | $1.2245 |
| 52-week low | $1.2245 |
| Median price | $1.3876 |
| Average price | $1.5557 |
| Largest weekly change | +182.1% (Feb 21, 2024) |
| Weeks tracked | 638 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the oxymorphone hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of OXYMORPHONE HCL 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYMORPHONE HCL 10 MG TABLET, manufactured by Hikma Pharmaceuticals USA Inc., is $1.2245 per EA (NDC 00054028425), effective May 13, 2026.
How has the price of OXYMORPHONE HCL 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYMORPHONE HCL 10 MG TABLET has declined 66.2%. It has been tracked across 638 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for OXYMORPHONE HCL 10 MG TABLET?
Since Nov 28, 2013, the NADAC for OXYMORPHONE HCL 10 MG TABLET has ranged from a low of $0.2729 (Jul 21, 2021) to a high of $3.7252 (Jan 15, 2014), with a median of $1.3876 per EA.
Are there cheaper alternatives to OXYMORPHONE HCL 10 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of OXYMORPHONE HCL 10 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures OXYMORPHONE HCL 10 MG TABLET?
OXYMORPHONE HCL 10 MG TABLET (NDC 00054028425) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification